| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | Aug 13, 2025 | Aldeyra Therapeutics, Inc. | Chief Development Officer | Sell | 42.5 | -22,073 | -9.05% | ✗ | $113.7K |
| Aug 12, 2024 | Aug 14, 2024 | Aldeyra Therapeutics, Inc. | Chief Development Officer | Sell | 42.5 | -16,041 | -6.35% | ✗ | $76K |
| Mar 12, 2024 | Apr 17, 2024 | Aldeyra Therapeutics, Inc. | Chief Development Officer | Sell | 46.3 | -11,537 | -4.36% | ✗ | $36.5K |
| Mar 11, 2024 | Mar 12, 2024 | Aldeyra Therapeutics, Inc. | Chief Development Officer | Sell | 42.5 | -29,768 | -10.89% | ✗ | $98.6K |